Patent intelligence · US
US 10138466
Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells
Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells
Patent details — US 10138466
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 27, 2018
- Expiration
- Nov 22, 2038
- Applicant
- REGENERATIVE MEDICAL SOLUTIONS, INC.
- Claims
- 16
- CPC classes
- A61K, A61K35/39, A61K35/545, A61K45/06
Quick answer
US 10138466 (Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells) is held by REGENERATIVE MEDICAL SOLUTIONS, INC.. Status: granted. Granted Nov 27, 2018. Expires Nov 22, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- REGENERATIVE MEDICAL SOLUTIONS, INC.
- Grant date
- Expiration
- Claims
- 16
- CPC classes
- A61K, A61K35/39, A61K35/545, A61K45/06, A61K9/1652, A61K9/5036
More from REGENERATIVE MEDICAL SOLUTIONS, INC.
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 10138466?
US 10138466 (Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells) is held by REGENERATIVE MEDICAL SOLUTIONS, INC.. Status: granted. Granted Nov 27, 2018. Expires Nov 22, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10138466?
REGENERATIVE MEDICAL SOLUTIONS, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 10138466 expire?
Our index shows an expiration date of Nov 22, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.